Original Research
Published on 21 Jul 2021
Cardiovascular Toxicity Induced by Chronic Vincristine Treatment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2021.692970
- 11,946 views
- 28 citations
59 articles related to "Cardiovascular Toxicity"
Articles
Review
Published on 27 Apr 2021
Epigenetic Mechanisms Involved in the Cardiovascular Toxicity of Anticancer Drugs
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2021.658900
- 7,550 views
- 19 citations
Original Research
Published on 04 Aug 2023
Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2023.1213771
- 4,471 views
- 6 citations
Review
Published on 05 Jul 2023
Cardiovascular toxicity from therapies for light chain amyloidosis
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1212983
- 7,856 views
- 5 citations
Review
Published on 13 Aug 2025
Cardiovascular toxicity in testicular germ cell tumor survivors
in Cardio-Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1654063
- 3,593 views
- 5 citations
Review
Published on 10 Mar 2026
Cardiotoxicity associated with anticancer therapies for gynecological tumors
in Cardio-Oncology
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2026.1779990
- 444 views
Original Research
Published on 18 Oct 2021
Evaluation of CML TKI Induced Cardiovascular Toxicity and Development of Potential Rescue Strategies in a Zebrafish Model
in Predictive Toxicology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.740529
- 7,748 views
- 11 citations
Mini Review
Published on 29 Mar 2021
New Modalities of 3D Pluripotent Stem Cell-Based Assays in Cardiovascular Toxicity
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.603016
- 6,643 views
- 10 citations
Review
Published on 06 Jan 2026
Advancements in research on the cardiovascular toxicity caused by TEC family kinases inhibitors
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1726458
- 1,740 views
- 1 citation
Original Research
Published on 02 Dec 2024
Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472008
- 5,407 views
- 5 citations
Review
Published on 03 Feb 2023
Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7
in General Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1002438
- 8,203 views
- 9 citations
Original Research
Published on 22 Jan 2025
Cardiovascular toxicity of tisagenlecleucel in children and adolescents: analysis of spontaneous reports submitted to FAERS
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1499143
- 4,096 views
- 2 citations
Original Research
Published on 05 Apr 2018
Developing a Reliable Mouse Model for Cancer Therapy-Induced Cardiovascular Toxicity in Cancer Patients and Survivors
in Atherosclerosis and Vascular Medicine
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2018.00026
- 5,938 views
- 10 citations
Original Research
Published on 10 May 2024
The cardiovascular toxicity of polystyrene microplastics in rats: based on untargeted metabolomics analysis
in Drug Metabolism and Transport
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1336369
- 8,593 views
- 39 citations
Perspective
Published on 14 Jun 2024
Cardio-oncology in advanced prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1386597
- 6,099 views
- 7 citations
Review
Published on 04 Dec 2014
Cardiovascular Toxicities from Systemic Breast Cancer Therapy
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2014.00346
- 9,383 views
- 24 citations